Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-21 5:22 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 8.8% | 0 (Unchanged) | View |
| 2022-04-01 4:38 pm Sale | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,021,529 9.05% | -626,826 (-17.18%) | View |
| 2022-02-22 11:22 am Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,648,355 10.93% | 0 (Unchanged) | View |
| 2020-12-02 4:58 pm Purchase | 13D | MusclePharm Corp MSLP | Drexler Ryan Charles | 31,002,836 68% | 11,349,057 (+57.74%) | View |
| 2020-11-03 4:23 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,111,874 6.4% | 100,000 (+4.97%) | View |
| 2020-10-28 3:57 pm Sale | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,874 6.1% | -31 (-0.00%) | View |
| 2020-07-13 2:07 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,905 6.2% | 80,600 (+4.17%) | View |
| 2019-11-08 2:04 pm Sale | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,648,355 11.29% | -9,825 (-0.27%) | View |
| 2019-10-07 4:48 pm Purchase | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 3,658,180 11.32% | 730,503 (+24.95%) | View |
| 2019-09-18 5:22 pm Purchase | 13D | MusclePharm Corp MSLP | Drexler Ryan Charles | 19,653,779 58.8% | 1,236,039 (+6.71%) | View |
| 2019-08-22 4:15 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,931,305 12.6% | 47,792 (+2.54%) | View |
| 2019-08-02 6:02 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.12% | 0 (Unchanged) | View |
| 2019-03-12 4:18 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,883,513 12.3% | 240,208 (+14.62%) | View |
| 2018-08-24 5:22 pm Unchanged | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.87% | 0 (Unchanged) | View |
| 2018-07-25 4:50 pm Sale | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,643,305 11.2% | -13,088,362 (-88.85%) | View |
| 2018-07-24 4:27 pm Purchase | 13D | MusclePharm Corp MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 14,731,667 11.2% | 13,395,362 (+1002.42%) | View |
| 2018-06-29 5:23 pm Purchase | 13D | MusclePharm Corp MSLP | White Winston Select Asset Fund Series Fund MP-18 LLC | 2,927,677 19.87% | 2,927,677 (New Position) | View |